Correlation of survival with tumor histology, age, and prognostic risk group for previously untreated patients with advanced renal cell carcinoma (adv RCC) receiving temsirolimus (TEMSR) or interferon-alpha (IFN). - Dutcher,J.P.; Szczylik,C.; Tannir,N.; Benedetto,P.; Ruff,P.; Hsu,A.; Berkenblit,A.; Thiele,A.; Strahs,A.; Feingold,J. (Clin Oncol, 2007)